Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Pharmadrug Inc C.PHRX

Alternate Symbol(s):  LMLLF

PharmaDrug Inc. is a Canada-based specialty pharmaceutical company. The Company is focused on the research, development and commercialization of controlled-substances and natural medicines, such as psychedelics and previously approved drugs. The Company’s subsidiary, Sairiyo Therapeutics (Sairiyo), is a biotech company that specializes in researching and reformulating established natural medicines. Sairiyo is engaged in the development of its patented reformulation of cepharanthine, a drug that has shown substantial third party validated potential for the treatment of infectious diseases (including Covid-19) and rare cancers. In clinical research, Cepharanthine exhibits multiple pharmacological effects, including anti-oxidative, anti-inflammatory, immuno-regulatory, anti-cancer, anti-viral and anti-parasitic properties. Sairiyo is also conducting research and development (R&D) in the psychedelics space for the treatment of non-neuropsychiatric conditions.


CSE:PHRX - Post by User

Post by JefffCEOon Apr 01, 2021 3:11am
424 Views
Post# 32920782

Rollback or Massive Dilution

Rollback or Massive DilutionJust an honest set of questions....

1)   How many shares will be sold to pay for the $200 Million plus of clinical trials?

2)   If unable to sell enough shares at 9 cents, what will the rollback ratio be?

3)   Will the stock break above 10 cents again as that is the minimum price needed to sell 10 million shares to raise each $1 Million before discounts, commissions, legal, etc?

4) Is there any emperical data on the hair tonic deal or is it just anecdotal information from bald guys?

5) What is the website URL so one can buy the hair tonic?

7)  Who did the valuation report that can backup the company issuing 75 Million shares?

8) Why did the company issue 60 Million shares to buy a shell company in Holland with zero assets?

9) Who are the insitutional owners of the company?


<< Previous
Bullboard Posts
Next >>